NCC Medical Group is a globally recognized developer and manufacturer of neurophysiology diagnostic and monitoring technologies. As a nationally designated SRDI “Little Giant” enterprise, NCC represents a new generation of specialized medical technology companies that focus on innovation, precision engineering, and advanced research.
Founded in 1997, NCC has built more than two decades of expertise in neurophysiology technology development. The company’s primary research and manufacturing center is located in Shanghai, China, a major hub for medical technology innovation. Here, multidisciplinary engineering teams conduct advanced research in electrophysiology, biomedical signal processing, and intraoperative neuromonitoring technologies.
To support global quality standards and regulatory compliance, NCC operates an international quality management and compliance center in Singapore. This facility oversees global certification, product validation, and international regulatory alignment. Through this dual-center structure, NCC ensures that all products meet the highest global standards for medical device safety and reliability.
NCC specializes in a broad range of neurophysiology technologies, including intraoperative neuromonitoring systems (IONM), electroencephalography systems (EEG), polysomnography systems (PSG), electromyography systems (EMG), and specialized neurophysiology medical consumables. These solutions are used by hospitals worldwide for neurological diagnosis, sleep monitoring, and surgical nerve protection.
The company’s operational framework is built around three strategic pillars. The first pillar focuses on research and manufacturing, where NCC develops innovative neurophysiology technologies and ensures precision manufacturing. The second pillar is global sales and distribution, supporting international market expansion through strategic partnerships with distributors and healthcare institutions. The third pillar emphasizes clinical service and innovation, providing professional training and technical support through platforms such as the NeuGuard Service Platform and the NCC Innovation Academy.
NCC’s technologies are currently used in more than 50 countries and installed in over 5,000 hospitals across China. These systems support clinicians in performing accurate neurophysiology diagnostics and safe intraoperative monitoring. Hospitals ranging from leading academic medical centers to regional healthcare facilities rely on NCC solutions for advanced neurological care.
To further support healthcare professionals, NCC has established 31 training and technical support centers across China, providing hands-on education for clinicians and biomedical engineers. Through continuous training programs and academic collaboration, NCC helps healthcare institutions implement neurophysiology technologies effectively.
The company’s mission, “Safeguarding Life and Health,” reflects its commitment to advancing safer surgeries, improving diagnostic precision, and supporting high-quality patient care worldwide.
Copyright © NCC Medical Co., Ltd. - Privacy policy